Loading
Latest filing published 12 Feb 2026 for Avadel Pharmaceuticals PLC, €3.7M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Gregory J. Divis span 2 companies, the busiest being Avadel Pharmaceuticals PLC and Jaguar Health, Inc. Between 12 August 2020 and 12 February 2026, the trades on record add up to 9 filings.
No open-market sale appears; the market trades are 5 purchases worth €396k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 share grant and 1 option exercise.
Half of the purchases are above €90k and half below. Of 5 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 12 February 2026 with a transaction (€177k) in Avadel Pharmaceuticals PLC. The latest purchase dates back some time: it was published 683 days ago, on 10 December 2024. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations